Lexaria Bioscience (LEXX) EBIT Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
-567,847.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
-567,847.00 |
| Aug 31, 2025 |
107,752.00 |
| May 31, 2025 |
-8,051.00 |
| Feb 28, 2025 |
-112,035.00 |
| Nov 30, 2024 |
-70,994.00 |
| Aug 31, 2024 |
100,150.00 |
| May 31, 2024 |
101,473.00 |
| Feb 29, 2024 |
614,917.00 |
| Nov 30, 2023 |
98,170.00 |
| Aug 31, 2023 |
-310,365.00 |
| May 31, 2023 |
-66,444.00 |
| Feb 28, 2023 |
-188,336.00 |
| Nov 30, 2022 |
1.27 Mn |
| Aug 31, 2022 |
-49,990.00 |
| May 31, 2022 |
-116,743.00 |
| Feb 28, 2022 |
-415,125.00 |
| Nov 30, 2021 |
-1.43 Mn |
| Aug 31, 2021 |
132,765.00 |
| May 31, 2021 |
261,413.00 |
| Feb 28, 2021 |
225,219.00 |
